tak 044 has been researched along with Cruveilhier-Baumgarten Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fung, J; Gandhi, CR; Harvey, SA; Subbotin, VM; Thirunavukkarasu, C; Yang, Y | 1 |
| Gandhi, CR; Nemoto, EM; Subbotin, VM; Watkins, SC | 1 |
2 other study(ies) available for tak 044 and Cruveilhier-Baumgarten Syndrome
| Article | Year |
|---|---|
Endothelin receptor antagonist TAK-044 arrests and reverses the development of carbon tetrachloride induced cirrhosis in rats.
Topics: Animals; Carbon Tetrachloride; Disease Progression; Endothelin Receptor Antagonists; Endothelin-1; Hypertension, Portal; Liver; Liver Cirrhosis, Experimental; Male; Peptides, Cyclic; Rats; Rats, Sprague-Dawley; Receptors, Endothelin | 2004 |
An endothelin receptor antagonist TAK-044 ameliorates carbon tetrachloride-induced acute liver injury and portal hypertension in rats.
Topics: Animals; Carbon Tetrachloride; Cells, Cultured; Endothelin Receptor Antagonists; Endothelin-1; Hypertension, Portal; Liver; Liver Cirrhosis, Experimental; Male; Peptides, Cyclic; Rats; Rats, Sprague-Dawley; Receptors, Endothelin | 1998 |